Biotechnology

Tuesday Oct 24, 2023 - 10:35 am

InvestorNewsBreaks — Longeveron Inc. (NASDAQ: LGVN; LGVNR) Top-Line Results from Phase 2a Trial Spotlighted in Latest NNA Release

Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (“HLHS”), Alzheimer’s disease and Aging-Related Frailty, is featured in a recent NetworkNewsAudio (“NNA”) broadcast. The segment focuses on the company’s most recent announcement of its topline results from the CLEAR Mind phase 2a clinical trial of LGVN’s Lomecel-B(TM) for the treatment of mild…

Monday Oct 23, 2023 - 11:02 am

InvestorNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Announces Filing in Connection with Proposed Arrangement with Celly Nu

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions. Together with Celly Nutrition Corp. (“Celly Nu”), FSD Pharma today announced its filing on www.SEDARPlus.ca its management information circular and related materials in connection with the special meeting of FSD Pharma Securityholders (as defined in the company’s press release dated Oct. 5,…

Friday Oct 20, 2023 - 2:53 pm

InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Advancing Drive Toward Potential New GBM Treatment

CNS Pharmaceuticals (NASDAQ: CNSP) recently announced rapid enrollment in its potentially pivotal study involving its flagship drug candidate, Berubicin, and is moving closer to reporting the results of its drive toward a new treatment for the effectively incurable brain cancer glioblastoma (“GBM”). “The Texas-based company has clinical trial sites operating in the U.S., Italy, France, Spain, and Switzerland, to evaluate Berubicin’s performance against standard of…

Friday Oct 20, 2023 - 2:00 pm

InvestorNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) CEO Participating in Webinar Focused on Future Health Tech

Renovaro BioSciences (NASDAQ: RENB) (formerly NASDAQ: ENOB), an advanced, preclinical biotechnology firm in cell, gene and immunotherapy focused on solid tumors with short life expectancy, will be spotlighted in webinar taking place today. The webinar is scheduled to start at 3 p.m. ET. Renovaro BioSciences CEO Mark Dybul will be featured in the webinar, which is titled “Future Health Tech: Challenges and Opportunities,” and will…

Thursday Oct 19, 2023 - 1:38 pm

InvestorNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Announces Participation at Upcoming Virtual Investor Ask the CEO Conference

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, will be featured at this month’s Virtual Investor Ask the CEO Conference. CNS Pharmaceuticals CEO John Climaco is scheduled to participate in a live moderated webcast during the conference; the webcast is slated to start at 4 p.m. ET.…

Thursday Oct 19, 2023 - 11:44 am

InvestorNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Spotlighted in Latest Episode of Bell2Bell Podcast

PaxMedica (NASDAQ: PXMD), a prominent clinical-stage biopharmaceutical company, was featured in the most recent release of the Bell2Bell podcast series. During the segment, PaxMedia CEO and chair Howard Weisman and PaxMedica corporate communications representative Buzz Woods provided an overview of the company’s latest accomplishments and future objectives with Bell2Bell host Stuart Smith. The trio discussed PaxMedia’s pioneering work in novel anti-purinergic drug therapies (“APT”) for…

Wednesday Oct 18, 2023 - 12:28 pm

InvestorNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) Featured in Bell2Bell Podcast

PaxMedica (NASDAQ: PXMD), a prominent clinical-stage biopharmaceutical firm, was featured in the latest episode of the Bell2Bell Podcast, a part of IBN’s sustained effort to provide specialized content distribution via widespread syndication channels. PaxMedica’s CEO and Chairman Howard Weisman and Buzz Woods, from the company’s corporate communications department, joined the program to offer a compelling overview of the company’s recent achievements and future objectives. During…

Tuesday Oct 17, 2023 - 11:04 am

InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) ‘Innovates’ Investigational Drug with Patented Nanotechnology

Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, announced that it has innovated its investigational drug, CNM-Au8(R), with nanotechnology. Clene is evaluating CNM-Au8(R) for the treatment of neurodegenerative disease, and the innovation reflects the growing importance of nanotechnology in the drug space. The announcement noted that Clene’s nanotechnological approach was recently awarded…

Monday Oct 16, 2023 - 12:15 pm

InvestorNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Innovative Glioblastoma Treatment ‘Could Offer Hope’

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, is spotlighted in a recent article focused on glioblastoma, the most aggressive type of brain cancer. Noting that glioblastoma has an average survival of only 14 to 16 months after diagnosis, the article points out that currently, glioblastoma has no cure…

Monday Oct 16, 2023 - 11:11 am

InvestorNewsBreaks – Safety Shot (NASDAQ: SHOT) Announces MMA Superstar Jorge “Gamebred” Masvidal as Brand Ambassador

Safety Shot (NASDAQ: SHOT), a wellness and functional beverage company, has sealed a deal with mixed martial arts (“MMA”) superstar Jorge Masvidal. The agreement calls for Masvidal to serve as brand ambassador for Safety Shot, the first patented beverage on Earth that helps people feel better faster by reducing blood alcohol content and boosting clarity. Safety Shot announced that agreement after becoming a ring sponsor…

Monday Oct 16, 2023 - 9:35 am

InvestorNewsBreaks — Longeveron Inc. (NASDAQ: LGVN; LGVNR) Closes on $4M Registered Direct Offering

Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (“HLHS”), Alzheimer’s disease and Aging-Related Frailty, closed on its previously announced registered direct offering. The offering was comprised of 2,424,243 shares of Class A common stock or common stock equivalents priced at $1.65 per share, or common stock equivalent. In addition, Longeveron issued unregistered…

Friday Oct 13, 2023 - 2:24 pm

InvestorNewsBreaks — Octane Selects IBN as Official Media Partner for Upcoming Medical Innovation Forum

Octane, a convening organization of the Southern California technology and medical technology business ecosystem, is partnering with IBN (“InvestorBrandNetwork”), a pioneering corporate communications firm and content distributor, to provide key communications and coverage of Octane’s Medical Innovation Forum. According to the announcement, IBN will serve as Official Media Partner for the event, with IBN’s InvestorWire serving as the Official NewsWire. The two-day forum is slated for…

Thursday Oct 12, 2023 - 3:34 pm

InvestorNewsBreaks – NextPlat Corp. (NASDAQ: NXPL) Announces Launch of OPKO Health Inc. (NASDAQ: OPK)-Branded Online Storefront

NextPlat (NASDAQ: NXPL, NXPLW), a global e-commerce provider, today announced that, through a new e-commerce distribution agreement, it will enable the online sales of OPKO Health Europe, a subsidiary of OPKO Health (NASDAQ: OPK) products in China. Under the agreement terms, NextPlat will launch a OPKO Health-branded online storefront on Alibaba Group Holding Limited's (NYSE: BABA) Tmall Global e-commerce platform in China featuring an assortment…

Thursday Oct 12, 2023 - 1:08 pm

InvestorNewsBreaks – Octane’s Upcoming Forum to Feature Visionaries, Cutting-Edge Advances in Medical Technology Space

Octane, a strategic partner for emerging companies, today announced details of this year’s Octane 2023 Medical Innovation Forum. The two-day event is slated to take place at the Irvine Marriott in Irvine, California, on October 25-26, 2023. The forum will feature some of the medical technology sector’s most visionary speakers, granting access to invaluable educational opportunities, showcasing cutting-edge technological advances, and providing a prime networking…

Thursday Oct 12, 2023 - 11:01 am

InvestorNewsBreaks – Safety Shot Inc. (NASDAQ: SHOT) Announces Significant BAC Reduction Results vs Control from New Product Study

Safety Shot (NASDAQ: SHOT) today announced results from a product test of Safety Shot(TM), the world’s first patented beverage that helps people feel better faster by reducing blood alcohol content and boosting clarity. According to the announcement, a study was conducted with volunteers, where subjects were served alcohol for one hour, then asked to stop drinking for 30 minutes. After this time, the volunteers went…

Thursday Oct 12, 2023 - 10:40 am

InvestorNewsBreaks — Longeveron Inc. (NASDAQ: LGVN; LGVNR) Enters into $4M Registered Direct Offering

Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (“HLHS”), Alzheimer’s disease and Aging-Related Frailty, has entered into a definitive agreement for the issuance and sale shares of its common stock. Specifically, the agreement calls for the issue and sale of 2,424,243 shares of Class A common stock, or common stock equivalents,…

Wednesday Oct 11, 2023 - 1:23 pm

InvestorNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) Appoints Intel Capital Cofounder to Board

Renovaro BioSciences (NASDAQ: RENB), a biotechnology corporation focusing on cell, gene and immunotherapy, has announced a new member of its board of directors. Avram Miller, cofounder of Intel Capital, will join the board and will also serve in an advisory role, bringing his invaluable experience to contribute to the company's strategy and business development efforts. Miller’s impressive decades-long career includes strategic and responsible roles in both…

Wednesday Oct 11, 2023 - 1:11 pm

InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports Rapid Pace of Enrollment in Potentially Pivotal Berubicin Study

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, is reporting enrollment of 229 participants in its ongoing potentially pivotal study evaluating Berubicin for the treatment of recurrent GBM, an aggressive and incurable form of brain cancer; the company expects to ultimately enroll 243 in the study. Participants are being…

Tuesday Oct 10, 2023 - 1:32 pm

InvestorNewsBreaks – Safety Shot Inc. (NASDAQ: SHOT) Welcomes COO Jarrett Boon to Its Board of Directors

Safety Shot (NASDAQ: SHOT) today announced that Jarrett Boon, who has served as the company’s chief operating officer since August 2023, has been appointed to Safety Shot’s board of directors. Boon is leading the launch and growth of the company’s Safety Shot functional drink business this quarter. Boon was the co-founder and CEO of GBB Drink Lab, which developed Safety Shot, the first patented beverage…

Tuesday Oct 10, 2023 - 1:27 pm

InvestorNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Announces Strategic Board Appointments of Two Finance Industry Experts

Renovaro BioSciences (NASDAQ: RENB), an advanced, pre-clinical biotechnology firm in cell, gene and immunotherapy focused on solid tumors with short life expectancy, today announced the appointment of Leni Boeren and Ruud Hendriks as independent directors. Both Boeren and Hendriks bring extensive, high-level experience in finance and business. Boeren has a 40-year career in the financial sector, commencing with banking roles at Paribas and Rabobank before…

Tuesday Oct 10, 2023 - 1:09 pm

InvestorNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) to Serve as Gold Sponsor of Synchrony Symposia 2023

PaxMedica (NASDAQ: PXMD), a clinical stage biopharmaceutical company focusing on the development of novel anti-purinergic drug therapies (“APT”) for the treatment of autism spectrum disorder (“ASD”) and other serious conditions, today announced its Gold Sponsorship of The BRAIN Foundation's esteemed Synchrony Symposia 2023. The globally recognized event serves as a catalyst for translational research in autism and related neurodevelopmental disorders and brings together leading scientists,…

Tuesday Oct 10, 2023 - 11:32 am

InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) CEO Featured in Latest Episode of The Bell2Bell Podcast

Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, is featured in the latest Bell2Bell Podcast release. During the segment, podcast host Stuart Smith discusses the company with Clene president and CEO Rob Etherington, who explains Clene’s business model and provides an overview of recent developments, which provide hope to those affected by…

Tuesday Oct 10, 2023 - 11:25 am

InvestorNewsBreaks – SOHM, Inc. (SHMN), UACI Collaborate to Advance ABBIE, a Groundbreaking Non-Viral Gene-Editing Technology

SOHM (OTC: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, today announced its entry into development collaboration with the University of Arizona Center for Innovation (“UACI”) to propel ABBIE, a non-viral gene-editing kit technology. UACI is a leading science and tech startup incubator that is directly connected to the University of Arizona, which is renowned for…

Monday Oct 09, 2023 - 1:13 pm

InvestorNewsBreaks – IBN, BioMedWire to Provide Dedicated Media Coverage for Upcoming BioPharma Nexus Events

InvestorBrandNetwork (“IBN”), a dynamic communications organization, today announced its collaboration with BioPharma Nexus as an official media partner for its events this month. In addition, BioMedWire, a specialized communications platform dedicated to the life sciences sector and a key part of IBN’s Dynamic Brand Portfolio (“DBP”), will serve as an official media partner. For each of the events, IBN and BioMedWire will leverage advanced communications…

Monday Oct 09, 2023 - 12:24 pm

InvestorNewsBreaks – ROTH MKM’s Upcoming Conference to Feature Public Healthcare Companies Across Multiple Sub-Sectors

ROTH MKM, a full-service investment bank focused on serving growth companies and their investors, announced plans to host its 2023 Healthcare Opportunities Conference in New York City on Oct. 12, 2023. The event will provide pre-qualified institutional investors and healthcare industry professionals the opportunity to interact closely with C-level executives of approximately 25 public companies selected by ROTH’s research analysts. With a multiple sub-sector focus,…

Friday Oct 06, 2023 - 10:05 am

InvestorNewsBreaks – Safety Shot Holdings Inc. (NASDAQ: SHOT) Announces Ring Sponsorship of Jorge Masvidal’s Gamebred Bareknuckle MMA

Safety Shot (NASDAQ: SHOT) today announced its entry into an agreement with mixed martial arts (“MMA”) superstar Jorge Masvidal’s Gamebred Bareknuckle MMA, the world’s first bareknuckle MMA promotion. Over the next year, Safety Shot, the first patented beverage on Earth that helps people feel better faster by reducing blood alcohol content and boosting clarity, will be the ring sponsor for 12 Gamebred Bareknuckle matches. “Jorge…

Thursday Oct 05, 2023 - 11:06 am

InvestorNewsBreaks — Longeveron Inc. (NASDAQ: LGVN; LGVNR) Reports Top-Line Results for Phase 2a Lomecel-B Clinical Trial

Longeveron (NASDAQ: LGVN; LGVNR), a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (“HLHS”), Alzheimer’s disease and Aging-Related Frailty, has released top-line results for its phase 2a trial of its investigational product Lomecel-B(TM). The study evaluated Lomecel-B for the treatment of mild Alzheimer’s disease. According to the report, the primary endpoint of safety was met…

Wednesday Oct 04, 2023 - 2:05 pm

InvestorNewsBreaks – Estrella Immunopharma Inc. (NASDAQ: ESLA, ESLAW) Starts Trading After TradeUP Acquisition Corp., Estrella Biopharma Inc. Business Combination

Estrella Immunopharma (NASDAQ: ESLA, ESLAW), formerly known as TradeUP Acquisition Corp. (“UPTD”), has successful closed a business combination with Estrella Biopharma Inc. Estrella Biopharma is a preclinical-stage biopharmaceutical company focused on developing T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. According to the announcement, shares in the combined company — Estrella Immunopharma — began trading on Oct. 2,…

Wednesday Oct 04, 2023 - 1:03 pm

InvestorNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Announces Dismissal of Motion, Wins $2.8 Million Award

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, is reporting on the status of court action filed against it. The company announced that the Ontario Superior Court of Justice dismissed the motion to set aside an arbitration award to FSD Pharma;…

Wednesday Oct 04, 2023 - 11:22 am

InvestorNewsBreaks – NextPlat Corp. (NASDAQ: NXPL) to Present at Upcoming Dawson James Conference

NextPlat (NASDAQ: NXPL, NXPLW), a global e-commerce provider, today announced that it will present at the 8th Annual Dawson James Conference taking place at the Wyndam Grand Jupiter at Harbourside Place in Jupiter, Florida, on Thursday, Oct. 12, 2023. NextPlat Corp’s executive chairman and CEO Charles M. Fernandez will deliver the company’s presentation and conduct in-person, one-on-one meetings throughout the conference. Fernandez’s presentation is slated…

Wednesday Oct 04, 2023 - 9:47 am

InvestorNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Announces Participation at CPHI Barcelona 2023, Other Upcoming Events

Scinai Immunotherapeutics (NASDAQ: SCNI) today announced that it will showcase its CDMO services at CPHI Barcelona, one of the international pharmaceutical industry’s premier trade shows, taking place Oct. 24 to 26. Scinai’s CDMO offers upstream and downstream process development and scale-up for protein-based drugs, analytical method development, and cGMP manufacturing including aseptic filling to biopharmaceutical and biotech clients. According to the announcement, several members of…

Monday Oct 02, 2023 - 12:34 pm

InvestorNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) CEO Releases Shareholder Letter Regarding Agreement to Combine with Leading AI Company

Renovaro BioSciences (NASDAQ: RENB) (formerly NASDAQ: ENOB), an advanced, preclinical biotechnology firm in cell, gene and immunotherapy focused on solid tumors with short life expectancy, is sharing a shareholder letter from Renovaro CEO Mark R. Dybul, MD. In the letter, Dybul provides information about the definitive agreement the company recently signed with artificial intelligence company GEDiCube. In the letter, Dybul noted that the two companies…

Friday Sep 29, 2023 - 3:46 pm

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases FY 2023 Report, Shares Corporate Update

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, is reporting on the financial results for its fiscal year 2023, the period ending June 30, 2023. In addition, the company provided a status update on its pharmaceutical drug-development programs as well as the commercial segment for BayMedica LLC, its wholly owned subsidiary. Highlights of…

Thursday Sep 28, 2023 - 10:12 am

InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) Investigational Drug Focus of Study Published in Peer-Reviewed Journal

Clene (NASDAQ: CLNN) and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis, Parkinson’s disease, and multiple sclerosis, announced the publication of a scientific paper. The paper, which was published in the “Small” journal, describes the catalytic mechanism of action of CLNN’s investigational drug CNM-Au8(R).…

Wednesday Sep 27, 2023 - 11:51 am

InvestorNewsBreaks – CSurgeries, Sheltowee Network Partner to Relaunch Platform, Revolutionize Surgical Training

CSurgeries, a top-tier online surgical video journal, is collaborating with Sheltowee Network, a leading innovation commercialization company. According to the announcement, the two companies will work together to make high-quality, peer-reviewed surgical content more accessible for medical professionals and students around the world. CSurgeries is redesigning its platform to add new features as well as an invaluable library of surgical videos; the company is also…

Tuesday Sep 26, 2023 - 12:00 pm

InvestorNewsBreaks – SOHM, Inc. (SHMN) Announces Acquisition of World-Class Gene-Editing Platform

SOHM (OTC: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, today announced it has acquired ABBIE, a world-class gene-editing platform that can deliver genetic payloads using non-viral vectors. Through this acquisition, SOHM is well-positioned as a competitive player in the $5.3 billion gene-editing market in 2023, which is expected to grow to $10.8 billion by 2028…

Tuesday Sep 26, 2023 - 11:54 am

InvestorNewsBreaks – Safety Shot Holdings Inc. (NASDAQ: SHOT) Announces Board Appointment of the Honorable Jack Brewer, M.Ed.

Safety Shot (NASDAQ: SHOT) today announced that Jack Brewer, M.Ed. has joined the company’s advisory board. Brewer is an ordained minister who possesses a unique combination of expertise in the fields of global economic development, sports and finance through his roles as a successful entrepreneur, executive producer, news contributor and humanitarian. He currently serves as CEO and portfolio manager of The Brewer Group Inc., White…

Tuesday Sep 26, 2023 - 11:03 am

InvestorNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Names Experienced Leaders to New Senior Management Positions

HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed the first and only credit card-size 3D-vector electrocardiogram (“VECG”) platform for patient use at home allowing for the creation of rich data for AI, has appointed two new team leaders. The company announced that Richa Gujarati will serve as senior vice president over product, and Pooja Chatterjee will be vice president over clinical. The two…

Friday Sep 22, 2023 - 2:24 pm

InvestorNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) Making Significant Strides to Advance Cellular Therapy Programs

Longeveron (NASDAQ: LGVN) is a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic conditions such as hypoplastic left heart syndrome (“HLHS”), Alzheimer’s disease and Aging-related Frailty. “The company is guided by the mission to advance cell-based product candidates into pivotal phase 3 trials, with the goal of attaining regulatory approvals and subsequently commercializing the product. Longeveron has so far made significant strides in…

Friday Sep 22, 2023 - 1:59 pm

InvestorNewsBreaks – RVL Pharmaceuticals plc (NASDAQ: RVLP) Anticipating Growing Demand for UPNEEQ(R)

RVL Pharmaceuticals (NASDAQ: RVLP) is a a specialty pharmaceutical company whose near-term focus is to continue the rollout of UPNEEQ(R) into the medical aesthetics market through its dedicated sales force. “UPNEEQ(R) is the first non-surgical treatment option approved by the U.S. Food and Drug Administration (‘FDA’) for acquired blepharoptosis… UPNEEQ(R), the first and only FDA-approved eye drop for low-lying eyelids, fits into the non-invasive medical…

InvestorNewsBreaks

NewsBreak Category: Biotechnology

Get Started with InvestorWire

Press Distribution

Explore Press Distribution Solutions

Discover Add-on Solutions